Early interim CT is the strongest prognostic factor in metastatic gastrointestinal neuroendocrine carcinomas (GI-NEC): results from the French NECTAR study
Early interim CT is the strongest prognostic factor in metastatic gastrointestinal neuroendocrine carcinomas (GI-NEC): results from the French NECTAR study. // ESMO Gastrointestinal Oncology. – URL: https://www.sciencedirect.com/science/article/pii/S2949819826001433?dgcid=rss_sd_all
Early interim CT is the strongest prognostic factor in metastatic gastrointestinal neuroendocrine carcinomas (GI-NEC): results from the French NECTAR study. ESMO Gastrointestinal Oncology. https://www.sciencedirect.com/science/article/pii/S2949819826001433?dgcid=rss_sd_all
“Early interim CT is the strongest prognostic factor in metastatic gastrointestinal neuroendocrine carcinomas (GI-NEC): results from the French NECTAR study.” ESMO Gastrointestinal Oncology.
@article{article93720,
title = {Early interim CT is the strongest prognostic factor in metastatic gastrointestinal neuroendocrine carcinomas (GI-NEC): results from the French NECTAR study},
journal = {ESMO Gastrointestinal Oncology},
url = {https://www.sciencedirect.com/science/article/pii/S2949819826001433?dgcid=rss_sd_all}
}